Figure 5b (left panel) has been corrected. The arrows have been repositioned for some of the cell lines to indicate their p53 wild-type status based on our published data (CellMiner, http://discover.nci.nih.gov/ cellminer/mutationGeneLoad.do, and ongoing exome sequencing of the NCI60).
This change strengthens our conclusions that endogenously activated Chk2 (pT68-Chk2) is only observed in p53-defective cells. All the 16 cell lines with wild-type p53 were negative for activated Chk2 whereas the 8 cell lines (including HeLa) with activated Chk2 were all p53 defective (Po0.05, w 2 , two-sided).
The Corrected Figure 5 is shown on the next page.
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